跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利匹韦林注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rilpivirine Injection
Approved
化学药品
Rilpivirine Injection
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Oct 18, 2023
Approval ID
8VIXzVXDJWN
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8VIXzVXDJWN
Approval Number
国药准字HJ20230117
Generic Name
利匹韦林注射液
Generic Name En
Rilpivirine Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
2ml∶0.6g
Reg Date
2023-10-18
Expired Date
2028-10-17
Company Name
Janssen-Cilag International NV
Production Company Name
Cilag AG
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 18, 2023
Approval ID
8VIXzVXDJWN
Type
化学药品
Back to NMPA Approvals